Articles tagged with Cancer Patients
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
The study found that social distancing policies implemented in the US and globally led to significant reductions in SARS-CoV-2 transmission, with an estimated 1.57 million cases prevented over a two-week period. The researchers also observed a strong correlation between decreased mobility and reduced virus transmission.
A case series evaluates radiotherapy delivery to 209 cancer patients during the COVID-19 outbreak. Key findings include improved outcomes and reduced treatment delays.
A consensus statement evaluates the use of prognostic genetic expression profile testing in melanoma, cautioning against routine use due to limitations. The statement aims to assist clinicians in determining when and how gene expression profiling should be adopted in clinical practice.
Researchers developed an AI algorithm to analyse tissue samples from cancer patients, distinguishing between healthy and cancerous tissues and identifying patterns of DNA and RNA changes. The study highlights the potential of AI for improving cancer diagnosis, prognosis, and treatment.
Researchers discovered that almost 20% of patients with unexplained intestinal polyps had tumors with mutations similar to those caused by colibactin, a bacterial toxin. Regular tooth brushing may have prevented the bacterial infection that triggered these cancer-causing DNA mutations.
Research from the Sidney Kimmel Cancer Center found significant decreases nationwide in cancer-related care, including a -56.9% decline in any neoplasm encounters and a 74% drop in new incidence neoplasms. Mammograms declined by 89.2% and colorectal cancer screenings fell by 84.5% during the pandemic.
The COVID-19 pandemic has exacerbated social isolation and distress among cancer patients, emphasizing the importance of human connection in their care. Clinicians can support these patients by fostering connections through non-clinical interventions.
A new study suggests that a simple urine test could significantly improve the detection of adrenal cancer by detecting excess adrenal steroid hormones. The test was found to be more accurate than imaging tests in diagnosing cancerous adrenal masses, potentially reducing unnecessary surgeries and healthcare costs.
Dr Patricia Ganz shares her expertise on assessing quality of life in cancer patients, with a focus on breast cancer survivorship. She highlights the importance of centering patients' needs in both US and UK healthcare systems.
Researchers at Hollings Cancer Center are studying T-cell exhaustion in the tumor microenvironment to discover ways to revitalize immunity against tumors. The team's work may lead to a new approach for immunotherapy by targeting the stress response that undermines T-cell function.
Research has found that cancer patients diagnosed over 24 months ago are more likely to experience severe COVID-19 infection. Patients from Asian ethnicity or receiving palliative treatment were also at a higher risk of death from COVID-19.
Newly released CCC19 data show a racial disparity in access to Remdesivir, an antiviral drug that shortens hospital stays, and increased mortality associated with dexamethasone, a steroid. Black patients were half as likely to receive Remdesivir as white patients.
Researchers found that some mutations actually generate 'noise' that can counteract cancer development, leading to a dead end. New drug combinations aim to reactivate suppressed pathways to disrupt oncogenic signal transduction in cancer cells.
A new study found that delays in cancer diagnosis due to the pandemic could result in more than 1,000 excess deaths in England. The researchers suggest prioritizing certain tumor types and ramping up diagnostic capacity to mitigate the impact of these delays.
Preliminary data suggests that immunotherapy won't worsen complications in patients with both conditions. Researchers found that an anti-diabetic drug metformin can reduce protein production by immune cells, offering a potential treatment option for COVID-19 complications.
A $204,000 grant from the NCI will support research on sustainability of telemedicine for rural cancer patients. The study aims to identify factors allowing telemedicine to be sustained over time and its impact on patients.
Researchers investigate how antibodies affect varying outcomes in coronavirus patients, with potential implications for vaccine efficacy and treatment approaches. The team aims to identify conditions under which antibody-dependent enhancement occurs and develop new assays for therapeutic antibody screening.
The rapid adoption of telehealth services during the COVID-19 pandemic has raised concerns about care quality and safety. Experts warn that integrating essential components of traditional doctor visits into virtual care poses challenges, including physical exams, lab work, and imaging. However, telehealth also holds promise for improvi...
A new testing method has shown promise in rapidly identifying radiation sickness based on biomarkers measured through a single drop of blood. The test uses microRNAs to quantify the actual radiation dose absorbed, allowing for early and real-time identification of the condition to enable timely clinical interventions.
Researchers at Ohio State University found that blocking an enzyme used by glioblastoma cells to store fats may be a new way to treat the deadly disease. This approach could also apply to other types of cancers that use lipid droplets for energy.
A new study published in JNCI Cancer Spectrum found significant disparities in cancer mortality rates between one-star and five-star hospitals. The research examined 105,823 patients who underwent complex cancer procedures at 3,146 hospitals between 2013 and 2016.
The new volume uses a health equity approach to focus on factors associated with cancer disparities research and identifies potential solutions. Studies highlight the impact of lifestyle on breast cancer risk and link mammary gland development to breast cancer disparity.
A comprehensive proteomic analysis of 103 Chinese patients with lung adenocarcinoma revealed molecular characteristics associated with clinical outcomes and potential prognostic biomarkers. The study identified 27 potential plasma biomarkers and several drug targets for LUAD, providing new insights into the disease.
Scientists have discovered that a steroidal sex hormone, ecdysone, drastically alters intestinal stem cell behavior, affecting gut growth and function. The study found that ecdysone stimulates stem cell growth and causes the gut to grow in size, leading to changes in its structure and function.
A clinical trial is underway to test an immune booster, IMM-101, in cancer patients to prevent severe COVID-19. The study aims to boost the innate immune system and protect vulnerable populations from lung infections.
A new study by Beth Israel Deaconess Medical Center found that surgical delays of 30-40 days are associated with shorter survival times in patients with colon cancer. For pancreatic and gastric cancers, the results indicate that longer surgical delays may increase cancer progression and worsen patient outcomes.
A new patient-focused intervention, DISCO App, has been developed to improve patient-provider treatment cost discussions and related patient outcomes. The five-year grant-funded study will evaluate the effectiveness of the app in reducing financial toxicity among cancer patients.
A study using electronic health records found that AI can predict who is at higher risk of pancreatic cancer up to 20 months before diagnosis. The model could help narrow down the number of people needed to be screened, potentially reducing false positives and improving survival rates.
A new study shows that genomic mutation testing using the Idylla automated system can reduce wait times for test results from 15 days to just 5 days. This allows patients to begin treatment for colorectal cancer sooner.
Researchers developed a machine learning predictive model to predict nephrotoxicity risk in testicular cancer patients using Danish patient data. The model correctly predicted 67% of high-risk patients and 92% of low-risk patients who did not develop nephrotoxicity.
A new study found that Black patients with early-stage esophageal cancer are less likely to receive life-saving surgery, contributing to their higher mortality rates. The study, which analyzed data from over 60,000 patients, suggests that education and targeted interventions are needed to address these disparities.
A new study from Memorial Sloan Kettering Cancer Center found that patients with active cancer treatment who develop COVID-19 illness do not fare any worse than other hospitalized patients. The study, published in Nature Medicine, suggests that no one should delay cancer treatment due to concerns about the virus.
A new international trial published in the Journal of Clinical Oncology suggests that carboplatin-paclitaxel is the optimal chemotherapy regimen for treating inoperable anal cancer. The study found a trend toward improved survival and less toxicity compared to cisplatin-5FU, with overall survival rates of 20 months vs 12.3 months.
PATRIOT analysis uses organoids to identify potential therapeutic targets in tumor cells, providing a holistic assessment of patient tumors. This allows for improved therapy recommendations and expanded personalized therapy options for cancer patients.
A new study found that patients' quality of life during the pandemic was significantly lower than a reference group, mainly due to social and cognitive functioning. Cancer patients considered postponing or abandoning treatment due to fear of COVID-19 morbidity and cancer progression.
A recent study by the University of Texas M. D. Anderson Cancer Center found that greater inactivity is independently associated with a higher risk of dying from cancer. Replacing sedentary time with physical activity, such as 30 minutes of cycling or walking, can lower this risk.
The InterAAct trial found carboplatin-paclitaxel to be the optimal chemotherapy regimen for inoperable anal cancer, with a lower risk of adverse events and improved overall survival. Patients treated with this regimen experienced a trend towards better survival rates, suggesting it should become the standard of care.
A patient-personalized sequencing pipeline, INVAR, enhances the sensitivity of circulating tumor DNA (ctDNA) detection in plasma samples. This technique analyzes hundreds of patient-specific mutations to detect ctDNA, enabling more accurate monitoring and potentially early relapse spotting.
Researchers discovered a novel combination of biomarkers from baseline tumor tissues that predict improved clinical responses and prolonged survival in patients with advanced bladder cancer. ARID1A mutations and CXCL13 expression were associated with better overall survival, suggesting potential patient selection improvements.
Researchers from the University of South Australia suggest that Vitamin D could mitigate chemotherapy-induced intestinal mucositis by suppressing inflammation and enhancing T-cell function. The study highlights the potential benefits of Vitamin D in reducing damage to the gut microbiome caused by chemotherapy agents.
This study evaluated the relationship between preoperative Geriatric Nutritional Risk Index and long-term outcomes in elderly gastric cancer patients. The results showed that the GNRI is a useful prognostic indicator for estimating overall survival, cancer-specific survival, and postoperative outcomes.
The study found that patients treated with chemotherapy had a significantly increased risk of dying from COVID-19, while those on anticoagulants and corticosteroids also faced higher mortality risks. In contrast, immunotherapies showed no increased risk of mortality.
A new Australian-developed treatment decision model, dubbed AUS-rule, has allowed more young cancer patients to recover from mild infections at home. The rule considers platelet and white cell counts and chemotherapy intensity to guide doctors in deciding whether patients can be treated and supported at home.
Researchers found that skeletal muscles release interleukin-15, which helps to settle and activate T-cell precursors. This enables the immune system to fight chronic infections over long periods. Regular training may strengthen the immune system by increasing muscle mass.
A randomised clinical trial has shown that a chemotherapy combination of carboplatin and paclitaxel is more effective and better tolerated than previously recommended treatments for patients with advanced anal cancer. The study found that these patients lived seven months longer overall, experiencing less treatment side effects.
Researchers at Hollings Cancer Center found a strong association between elevated AGEs in the body and breast cancer risk, particularly among women consuming high-AGE diets. The study's results suggest that reducing AGE intake through healthier food choices and physical activity may help lower cancer risk.
A study combining 15 observational studies with 9,500 patients compared the risk of cancer recurrence and death associated with minimally invasive versus open radical hysterectomy for early-stage cervical cancer. The results showed no significant difference in overall survival between the two groups.
Ashion Analytics has been certified for the National Cancer Institute's MATCH program, offering a comprehensive genomic analysis of all possible cancer mutations in DNA and RNA. This allows for personalized treatment options and potentially life-changing outcomes.
A new AI-driven system called ModGraProDep has been developed to predict cancer survival and risk. This innovative tool uses probabilistic modeling and machine learning to provide personalized predictions for patients, enabling more effective treatment planning and improved patient outcomes.
A randomized trial of a hospice video educational tool found that patients who viewed the video were more likely to prefer hospice at end-of-life and had longer hospice use compared to those receiving verbal descriptions. Caregivers also reported greater knowledge and preferences for hospice care after viewing the video.
Recent studies by Hollings Cancer Center researcher Chanita Hughes-Halbert highlight the importance of effective chronic disease prevention and management for male minority prostate cancer patients and veterans. The research emphasizes the need for better training programs and social determinants-based approaches to address underlying ...
Researchers found that 40.2% of advanced cancer patients experienced functional impairment upon hospitalization, leading to longer stays and worse outcomes. Interventions addressing this issue could enhance care delivery and outcomes for highly symptomatic patients.
Oncology pharmacy practitioners worldwide are struggling with limited and restricted PPE supply, making it difficult for them to provide high-quality cancer care. In a study, half of the surveyed countries reported impaired access to essential medications, including anti-infective agents and anticancer medications.
Researchers found that blocking Bruton tyrosine kinase (BTK) protein with acalabrutinib reduced inflammation and improved breathing in patients with severe COVID-19. The study suggests a potential new treatment approach for hospitalized patients with low blood-oxygen levels and evidence of inflammation.
Researchers at Dartmouth Health have found that HPV vaccines effective in the US may not provide adequate protection for women in low- and middle-income countries due to differing prevalence of HPV strains. This has significant implications for cervical cancer prevention and treatment in these regions.
Researchers discovered that cancer cells generate a high number of errors when copying their DNA under treatment, fuelling resistance. Combining targeted therapy with DNA repair mechanism-targeting drugs may lead to more effective therapeutic strategies.
A new study led by Ohio State University researchers has identified a protein within immune cells called PCBP1 that helps shape optimal immune responses to cancer. Higher PCBP1 activity promotes cytotoxic T-cell functions, while lower levels trigger the expression of factors that suppress cancer immune responses.
A large international trial found that pembrolizumab more than doubled the progression-free survival time of patients with a specific subtype of advanced bowel cancer, compared to chemotherapy. The treatment also showed durable benefits, with 48.3% of patients experiencing no disease progression after two years.
Researchers found that patients in Huntsman at Home had reduced hospitalizations, emergency department visits, and cumulative charges compared to controls. The study demonstrated strong evidence for the care model, showing improved patient outcomes while improving value.
A Phase II clinical trial has demonstrated a 46.5% objective response rate to tepotinib in patients with advanced non-small cell lung cancer and the MET exon 14 skipping mutation. The study's findings provide a new treatment option for this elderly population, with a durable response lasting almost one year.